Clinical Study

Anemia In End Stage Renal Disease Study Testing And Investigational Drug Daprodustat Anemia Pill Vs. The Standard Of Care (Aranesp) Injections.

Posted Date: May 15, 2019

  • Investigator: Shashi Kant
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to test how effective daprodustat (an investigational medicine which has not yet been approved by regulatory agencies such as the United States Food and Drug Administration (FDA)) is compared with epoetin alfa or darbepoetin alfa (which has been approved) (called EPO fro


Patients With End Stage Renal Disease Currently On Hemodialysis Or Peritoneal Dialysis For > 90 Days


Erythropoeisis Stimu, Anemia, Dialysis

For More Information:

Heather J Duncan, Phd

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.